Breast Cancer

The use of elacestrant, an investigational therapy, elicited a 30% reduction in the risk of disease progression or death compared with standard of care in a group of patients with estrogen receptor (ER)–positive, HER2-negative metastatic breast cancer.

Ibrance plus Faslodex improved progression-free survival in certain patients with metastatic breast cancer, compared with those who continued to receive an aromatase inhibitor.

Black race is associated with a 3.5-fold increased incidence of lymphedema in women with breast cancer treated with axillary lymph node dissection and radiotherapy, according to recent data.

CURE’s Metastatic Breast Cancer Heroes™ Award Program expresses gratitude to the heroes who impact the lives of patients with metastatic breast cancer.

A mother of a young breast cancer survivor shares the letter she wrote to Santa explaining her only Christmas wish.

Patients who understand their roles and responsibilities may better help their care teams understand what they may be at risk for in their cancer survivorship.

A male breast cancer survivor takes a critical look at the confusing marketing campaigns that surround his disease.

On this episode of the “Cancer Horizons” podcast, a man explains how his late wife’s breast cancer diagnosis changed his life and his understanding of the disease.

Certain post-menopausal women with HR-positive, HER2-negative breast cancer may be able to only undergo endocrine therapy after surgery – sparing themselves from the chemotherapy side effects.

Certain over-the-counter supplements can make chemotherapy less effective or even be the reason a breast cancer surgery is delayed.

By understanding family history, an individual can better reveal their genetic breast cancer risk and whether or not they are a candidate for genetic testing.

A breast cancer survivor describes the mixed bag of emotions she has about getting a routine mammogram the day before Thanksgiving, and how she remains joyous and thankful yet cautious and fearful.

Being informed and educated may help patients with breast cancer make a treatment decision and feel less afraid.

A caregiver and mother of a breast cancer survivor explains the common misunderstanding people have when asking how her daughter’s health post-treatment.

A woman living with metastatic breast cancer explains why TV commercials depicting carefree, happy people do not reflect the reality of her experience. “My life and the lives of those affected by metastatic breast cancer is anything but normal. Too many of us are dying every day,” she writes.

The panel provides closing thoughts on patient advocacy and advocacy activities.

Julie Larson, LCSW, provides insight into reasons for joining clinical trials, finding trials from peers, and trials for purposes other than cancer treatment.

On this episode of the “Cancer Horizons” podcast, actress and comedian Jessica St. Clair and writer Dan O’Brien share their cancer stories and how they channeled their emotions through creativity.

An expert explains what treatment strategies are available for patients with metastatic breast cancer, how far research has come and why patients shouldn’t lose hope.

The panel discusses resources available for locating relevant clinical trials for patients with metastatic breast cancer.

Shirley Mertz, MA, JD, provides an overview of clinical trials and how they are conducted.

A breast surgeon discusses what patients and their caregivers should know before breast cancer surgery.

Navigating discussions around treatments for early-stage breast cancer may be difficult, but feeling comfortable with one’s cancer team and knowing about all the available options may help.

View the full CURE Educated Patient Breast Cancer Summit Outside of Therapy Session on demand.

View the full CURE Educated Patient Breast Cancer Summit Novel Therapies Session on demand.

View the full CURE Educated Patient Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session on demand.

A woman who has been living with metastatic breast cancer for seven years reflects on the strangeness of her body aging. “It’s the one thing I never imagined would happen after being diagnosed with and while living with a terminal illness – I’m actually getting old,” she writes.

Sheila McGlown provides insight into the underrepresentation of women of color in clinical trials for breast cancer and discusses reasons for these disparities.

The panel elaborates on the racial disparities in the care of breast cancer and the need for systemic change to address these disparities.

A woman who had an aesthetic flat closure after her mastectomy due to breast cancer explains what the new “Simpsons” character, Dr. Wendy Sage means to her.